1. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways
    Zhi-Ping Zhou et al, 2018, International Journal of Oncology CrossRef
  2. Metabolites identification and pharmacokinetic profile of hirsuteine, a bioactive component in Uncaria in rats by ultra‐high performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry
    Wen Qi et al, 2022, Journal of Separation Science CrossRef
  3. ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
    Jing‐Quan Wang et al, 2021, Journal of Evidence-Based Medicine CrossRef
  4. Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism
    Qianqian Xu et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  5. Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism
    J. Wei et al, 2022, Clinical and Translational Oncology CrossRef
  6. Phytochemistry Profile, Antimicrobial and Antitumor Potential of the Methanolic Extract of Tabernaemontana catharinensis A DC and Eragrostis plana NEES
    Emanoeli da Rosa et al, 2024, Evidence-Based Complementary and Alternative Medicine CrossRef
  7. Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling
    Yaqi Kang et al, 2022, Phytomedicine CrossRef
  8. Recent research progress of Uncaria spp. based on alkaloids: phytochemistry, pharmacology and structural chemistry
    Nan Qin et al, 2021, European Journal of Medicinal Chemistry CrossRef
  9. Pharmacokinetics of isocorynoxeine in rat plasma after intraperitoneal administration by UPLC–MS/MS
    Haichao Zhan et al, 2020, Acta Chromatographica CrossRef
  10. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review
    Bethsebie Lalduhsaki Sailo et al, 2024, Cancers CrossRef
  11. Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1
    Shan Gao et al, 2022, Biomolecules & Therapeutics CrossRef
  12. Effects of hirsuteine on MDA‑MB‑453 breast cancer cell proliferation
    Jie Meng et al, 2022, Oncology Letters CrossRef
  13. Inhibitory effect and mechanism of hirsuteine on NCI‑H1299 lung cancer cell lines
    Xuelin Yun et al, 2023, Oncology Letters CrossRef
  14. Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role
    Sandra Kannampuzha et al, 2023, Medical Oncology CrossRef
  15. Advanced researches of traditional uses, phytochemistry, pharmacology, and toxicology of medical Uncariae Ramulus Cum Uncis
    Ruolian Cao et al, 2024, Journal of Ethnopharmacology CrossRef
  16. A Novel Rhynchophylline Analog, Y396, Inhibits Endothelial Dysfunction Induced by Oxidative Stress in Diabetes Through Epidermal Growth Factor Receptor
    Zhi-Jun Wang et al, 2020, Antioxidants & Redox Signaling CrossRef
  17. Mechanisms of lipopolysaccharide protection in tumor drug–induced macrophage damage
    Shuliang Song et al, 2024, International Journal of Biological Macromolecules CrossRef
  18. A SNP involved in alternative splicing of ABCB1 is associated with clopidogrel resistance in coronary heart disease in Chinese population
    Shasha Zhang et al, 2020, Aging CrossRef
  19. Overexpression of ABCC1 Confers Drug Resistance to Betulin
    Xuan-Yu Chen et al, 2021, Frontiers in Oncology CrossRef
  20. Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation
    Tingting Zou et al, 2021, Biomedicines CrossRef
  21. Design, synthesis and bioactivity investigation of peptide-camptothecin conjugates as anticancer agents with a potential to overcome drug resistance
    Chenyu Zhang et al, 2023, International Journal of Pharmaceutics CrossRef
  22. Therapeutic potential of tocotrienols as chemosensitizers in cancer therapy
    Bethsebie Lalduhsaki Sailo et al, 2024, Phytotherapy Research CrossRef